Processes and barriers to implementation of point-of-care genotype-guided dosing of warfarin into UK outpatient anticoagulation clinics-Reference-Cited by-同舟云学术

Processes and barriers to implementation of point-of-care genotype-guided dosing of warfarin into UK outpatient anticoagulation clinics

Published:2019-06 Issue:8 Volume:20 Page:599-608
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Fitzgerald Gail¹,Prince Clare¹,Downing Jennifer²,Reynolds Julia³,Zhang Jieying Eunice⁴,Hanson Anita¹,Alfirevic Ana⁵,Pirmohamed Munir⁶

Affiliation:

1. Research Nurse, Royal Liverpool & Broadgreen University Hospitals NHS Trust, Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK

2. Research Manager, NIHR CLAHRC NWC, University of Liverpool, Liverpool, UK

3. Associate Director, Innovation Agency, Academic Health Science Network for the North West Coast, Warrington, UK

4. Post-doctoral Research Associate, Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK

5. Professor of Pharmacology, University of Liverpool, Liverpool, UK

6. David Weatherall Chair of Medicine, University of Liverpool & Royal Liverpool & Broadgreen University Hospitals NHS Trust, Liverpool, UK

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2019-0021

Reference44 articles.

1. NHS England. The long term plan. (2019). https://www.longtermplan.nhs.uk/

2. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update

3. Emergency Hospitalizations for Adverse Drug Events in Older Americans

4. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

5. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons learned from the influence of CYP2C9 genotype on warfarin dosing;Expert Opinion on Drug Metabolism & Toxicology;2023-04-03

2. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing;Annual Review of Genomics and Human Genetics;2022-08-31

3. Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?;Expert Opinion on Pharmacotherapy;2021-01-29

4. Recommendations to protect patients and health care practices from Medicare and Medicaid fraud;Journal of the American Pharmacists Association;2020-11